Recovery of Glucose-Induced Insulin Secretion in a Rat Model of NIDDM Is Not Accompanied by Return of the B-Cell GLUT2 Glucose Transporter

The NSTZ rat model combines loss of glucose-induced insulin secretion with a reduced amount of the high Km B-cell glucose transporter, GLUT2. The purpose of this study was to determine whether the restoration of glucose-induced insulin secretion was paralleled by an increase of GLUT2. Rats injected at 2 days of age with 90 mg/kg STZ were studied at 8–13 wk of age. Insulin secretion was assessed in the isolated perfused pancreas with 16.7 mM glucose preceded by 40 min of 0 or 5.5 mM glucose. In control rats, 16.7 mM glucose caused the same large biphasic insulin response whether preceded by 0 or 5.5 mM glucose. In NSTZ rats, after 5.5 mM glucose, 16.7 mM glucose elicited virtually no rise in insulin release. In contrast, after 0 mM glucose, a large insulin response to the glucose challenge occurred that was equal to that of the control groups when the differences in B-cell mass were taken into account. However, the dose-response curve for glucose-induced insulin secretion was shifted to the left, and no second phase of insulin secretion was observed. GLUT2 was assessed after the perfusions by indirect immunofluorescence with anti-GLUT2 antisera. Both control groups showed homogenous staining in all B-cells. NSTZ rats perfused with 5.5 mM glucose had a marked diminution in GLUT2 staining. We observed no increase in GLUT2 staining in the NSTZ rats perfused with 0 mM glucose. In summary, our results show: 1) the recovered glucose responsiveness in NSTZ rats after perfusion with 0 mM glucose appears in the presence of a reduced level of GLUT2; 2) the recovered glucose-induced insulin secretion is abnormal in that the glucose dose-response curve is shifted to lower glucose concentrations and a blunted second phase occurs. These results suggest that several steps are altered in the glucose signaling pathway of glucose unresponsive B-cells from NSTZ rats, and that a reduction of GLUT2 level may be only a partial cause of the secretory defects of diabetic B-cells.

[1]  R. Unger,et al.  Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells. , 1991, Science.

[2]  B. Jeanrenaud,et al.  Evolution of Insulin Secretory Response to Glucose by Perifused Islets From Lean (FA/FA) Rats Chronically Infused With Glucose , 1991, Diabetes.

[3]  J. H. Johnson,et al.  Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Bhathena,et al.  Multiple Alterations in Insulin Responses to Glucose in Islets From 48-h Glucose-Infused Nondiabetic Rats , 1990, Diabetes.

[5]  J. H. Johnson,et al.  Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes , 1990, Science.

[6]  J. Leahy.  Natural History of β-Cell Dysfunction in NIDDM , 1990, Diabetes Care.

[7]  H. Lodish,et al.  Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Pardridge,et al.  Downregulation of Blood-Brain Barrier Glucose Transporter in Experimental Diabetes , 1990, Diabetes.

[9]  J. H. Johnson,et al.  Regulation of beta-cell glucose transporter gene expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Rasmussen,et al.  Physiology and Pathophysiology of Insulin Secretion , 1990, Diabetes Care.

[11]  J. H. Johnson,et al.  The high Km glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. , 1990, The Journal of biological chemistry.

[12]  G I Bell,et al.  Molecular Biology of Mammalian Glucose Transporters , 1990, Diabetes Care.

[13]  H. Lodish,et al.  Molecular Physiology of Glucose Transporters , 1990, Diabetes Care.

[14]  W. Malaisse,et al.  Perturbation of pancreatic islet function in glucose-infused rats. , 1990, Metabolism: clinical and experimental.

[15]  P. Pilch.  Glucose transporters: what's in a name? , 1990, Endocrinology.

[16]  L. Orci,et al.  Localization of the pancreatic beta cell glucose transporter to specific plasma membrane domains. , 1989, Science.

[17]  N. Welsh,et al.  Insulin Production and Glucose Metabolism in Isolated Pancreatic Islets of Rats With NIDDM , 1988, Diabetes.

[18]  O. E. Michaelis,et al.  Reversible Impairment of Glucose-Induced Insulin Secretion in SHR/N-cp Rats: Genetic Model of Type II Diabetes , 1988, Diabetes.

[19]  V. Grill,et al.  B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia. , 1987, The Journal of clinical investigation.

[20]  B. Portha,et al.  Insulin Treatment Improves Glucose-Induced Insulin Release in Rats With NIDDM Induced by Streptozocin , 1987, Diabetes.

[21]  J. Leahy,et al.  Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. , 1986, The Journal of clinical investigation.

[22]  J. Leahy,et al.  Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes. , 1986, Diabetes/metabolism reviews.

[23]  F. Matschinsky,et al.  Pancreatic islet glucose metabolism and regulation of insulin secretion. , 1986, Diabetes/metabolism reviews.

[24]  B. Portha.  Decreased glucose-induced insulin release and biosynthesis by islets of rats with non-insulin-dependent diabetes: effect of tissue culture. , 1985, Endocrinology.

[25]  J. Leahy,et al.  Unresponsiveness to Glucose in a Streptozocin Model of Diabetes: Inappropriate Insulin and Glucagon Responses to a Reduction of Glucose Concentration , 1985, Diabetes.

[26]  S. Bonner-Weir,et al.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. , 1983, The Journal of clinical investigation.

[27]  S. Bonner-Weir,et al.  Elevated Proinsulin Biosynthesis In Vitro from a Rat Model of Non-insulin-dependent Diabetes Mellitus , 1983, Diabetes.

[28]  J. P. Moulin,et al.  The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. , 1982, Metabolism: clinical and experimental.

[29]  A. Gjedde,et al.  Blood-brain glucose transfer: repression in chronic hyperglycemia. , 1981, Science.

[30]  S. Bonner-Weir,et al.  Islet Secretion in a New Experimental Model for Non-insulin-dependent Diabetes , 1981, Diabetes.

[31]  S. Bonner-Weir,et al.  Responses of Neonatal Rat Islets to Streptozotocin: Limited B-Cell Regeneration and Hyperglycemia , 1981, Diabetes.

[32]  H. Landahl,et al.  Comparison of storage- and signal-limited models of pancreatic insulin secretion. , 1980, The American journal of physiology.

[33]  J. Palmer,et al.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. , 1976, The Journal of clinical investigation.

[34]  I. W. Mclean,et al.  PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  G. Weir,et al.  Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines. , 1974, The Journal of clinical investigation.

[36]  R. Turner,et al.  A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. , 1972, Acta endocrinologica.

[37]  D. Kipnis,et al.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. , 1967, The Journal of clinical investigation.

[38]  R Luft,et al.  The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. , 1967, Acta endocrinologica.

[39]  M. T. Brennan,et al.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. , 1967, The Journal of clinical investigation.

[40]  G. L. Duff,et al.  Prevention and reversal despite hyperglycemia of glycogen infiltration ("hydropic degeneration") in the pancreas in alloxan diabetes in the rabbit. , 1951, Endocrinology.